Date:11/18/2009

from the report include: - COPD costs more than asthma and diabetes - The cost of COPD exceeds that of many other serious, long-term conditions including asthma and diabetes(7). The worldwide burden of COPD is nearly double that of diabetes and it causes more deaths(6). - Effective COPD treatment must look beyond smoking cessation - It is true that the primary cause of COPD is cigarette smoke(8) and smoking cessation is an important part of COPD management. Yet many former smokers develop symptoms and are diagnosed a decade or two after they stopped. In fact, even if all smoking stopped today, the effect on COPD statistics would not be seen for up to 20 years(9). - COPD puts pressure on healthcare systems - One in six European and U.S. patients had visited the ER or hospital in a six month period 2006-20075. Extrapolating these figures indicates that up to 64 million COPD patients globally may be admitted to hospital due to their condition each year. Additionally, a large majority of COPD patients suffer from co-morbidities, such as heart disease, high blood pressure and diabetes(10-13). In fact, 40 percent suffer from heart disease10 and as many as 42 percent from high blood pressure(12,13). - Families may also face burden - More women than men are now being be diagnosed with COPD(14) - a patient segment central to family care.

About COPD

Chronic obstructive pulmonary disease (COPD) is a debilitating, life-threatening and progressive lung disease that interferes with normal breathing(8). It is thought to cause around three million deaths per year - on average one person every 10 seconds(4). COPD refers to emphysema and chronic bronchitis - two commonly co-existing diseases of the lung. Due to lung deterioration, people with COPD experience symptoms like chronic shortness of breath and cough that impact the ability to
'/>"/>

SOURCE Education for Health Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
3. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
4. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
5. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
6. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
7. Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference
8. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
9. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
10. Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
11. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation